Abstract: Metastatic Crohn's disease is a rare extraintestinal manifestation of Crohn's disease. It is characterized by polymorphic skin lesions formed by non-caseating granulomas located on anatomical sites distant from the gastrointestinal tract. We report a rare case of metastatic Crohn's disease, simultaneously displaying multiple clinically heterogeneous cutaneous lesions, in a patient with previously diagnosed Crohn's disease in remission due to anti-TNF-α use. This case highlights the need for high clinical suspicion and early biopsy in the setting of a patient with Crohn's disease and persistent skin lesions, even under biologic therapy. Furthermore, it reinforces the need of monitoring of the serum level of infliximab, increasing the dose in case it is low or undetectable.
INTRODUCTION
Metastatic Crohn's disease (MCD) is a rare extraintestinal manifestation of Crohn's disease (CD), characterized by polymorphic cutaneous lesions formed by non-caseating granulomas localized in anatomical sites distant form the gastrointestinal tract.
We report a rare case of MCD with a generalized distribution and predilection for skin folds, in a patient with stable CD under treatment with infliximab.
CASE REPORT
A 36-year-old female patient presented to the clinic with erythematous, erosive and painful plaques on the perioral, perinasal, post-auricular and occipital regions ( Figure 1 ). She also had ill-defined, erythematous, scaly plaques on the trunk, axillae, buttocks, and inguinal region ( Figure 2 ). In addition, there was obvious edema of the vulva and mons pubis ( anti-TNF-α agents in more severe or refractory situations. 8 However, 
